BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27558760)

  • 1. Medication Nonadherence: The Role of Cost, Community, and Individual Factors.
    Abbass I; Revere L; Mitchell J; Appari A
    Health Serv Res; 2017 Aug; 52(4):1511-1533. PubMed ID: 27558760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Medicare Part D medication out-of-pocket costs with utilization of statin medications.
    Karaca-Mandic P; Swenson T; Abraham JM; Kane RL
    Health Serv Res; 2013 Aug; 48(4):1311-33. PubMed ID: 23278369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
    Axon DR; Vaffis S; Chinthammit C; Lott BE; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
    Bibeau WS; Fu H; Taylor AD; Kwan AY
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective cohort study evaluating the relationship between statin medication adherence and economic outcomes in commercial health plans.
    Chinthammit C; Axon DR; Anderson S; Lott B; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Clin Lipidol; 2020; 14(6):791-798. PubMed ID: 33011136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient, physician, and payment predictors of statin adherence.
    Chan DC; Shrank WH; Cutler D; Jan S; Fischer MA; Liu J; Avorn J; Solomon D; Brookhart MA; Choudhry NK
    Med Care; 2010 Mar; 48(3):196-202. PubMed ID: 19890219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between statin adherence level, health care costs, and utilization.
    Zhao Y; Zabriski S; Bertram C
    J Manag Care Spec Pharm; 2014 Jul; 20(7):703-13. PubMed ID: 24967523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated With Adherence to Statin Medications of Patients Enrolled in a Self-insured University Health Plan.
    Range JT; LaFontaine PR; Ryder PT; Polston M
    Clin Ther; 2018 Oct; 40(10):1692-1700. PubMed ID: 30231972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of prescription abandonment with cost share for high-cost specialty pharmacy medications.
    Gleason PP; Starner CI; Gunderson BW; Schafer JA; Sarran HS
    J Manag Care Pharm; 2009 Oct; 15(8):648-58. PubMed ID: 19803554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Out-of-Pocket Cost on Medication Initiation, Adherence, and Persistence among Patients with Type 2 Diabetes: The Diabetes Study of Northern California (DISTANCE).
    Karter AJ; Parker MM; Solomon MD; Lyles CR; Adams AS; Moffet HH; Reed ME
    Health Serv Res; 2018 Apr; 53(2):1227-1247. PubMed ID: 28474736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
    Bellows BK; Olsen CJ; Voelker J; Wander C
    J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of out-of-pocket pharmacy costs with adherence to varenicline.
    Suehs BT; Davis C; Galaznik A; Joshi AV; Zou KH; Patel NC
    J Manag Care Spec Pharm; 2014 Jun; 20(6):592-600. PubMed ID: 24856597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary nonadherence to statin medications in a managed care organization.
    Cheetham TC; Niu F; Green K; Scott RD; Derose SF; Vansomphone SS; Shin J; Tunceli K; Reynolds K
    J Manag Care Pharm; 2013 Jun; 19(5):367-73. PubMed ID: 23697474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma.
    Makhinova T; Barner JC; Richards KM; Rascati KL
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1124-32. PubMed ID: 26679962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Nonadherence to Topical Intraocular Pressure Reduction Medications Among Medicare Members: A Claims-Based Retrospective Cohort Study.
    Sheer R; Bunniran S; Uribe C; Fiscella RG; Patel VD; Chandwani HS
    J Manag Care Spec Pharm; 2016 Jul; 22(7):808-817a. PubMed ID: 27348282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs.
    Thornton Snider J; Seabury S; Lopez J; McKenzie S; Goldman DP
    Am J Manag Care; 2016 Jun; 22(6):433-40. PubMed ID: 27355811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
    Chinthammit C; Axon DR; Mollon L; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of adherence to oral anticancer medications: An analysis of 2010-2018 US nationwide claims.
    Vyas A; Descoteaux A; Kogut S; Parikh MA; Campbell PJ; Green A; Westrich K
    J Manag Care Spec Pharm; 2022 Aug; 28(8):831-844. PubMed ID: 35876294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.